Dr M Raj Nijanth

MBBS, MRCP (UK), FAMS (Neurology)

Associate Consultant

Specialty: Neurology

Sub-specialties: General Neurology

Conditions Treated by this Doctor:
General Neurology.

Clinical Appointments

Associate Consultant Department of Neurology National Neuroscience Institute

Profile

Dr Nijanth is an Associate Consultant in Neurology, National Neuroscience Institute (SGH Campus). He has a special interest in Migraine and headache disorders, Stroke, and rehabilitation. In addition to clinical practice, he is involved in education of students in various medical schools in Singapore. He has several publications in international journals and is actively involved in research.

Education

Specialist Accreditation in Neurology, Singapore 2023
Specialty Certificate in Neurology - Royal College of Physicians UK, 2021
MRCP UK - Member Royal Colleges of Physicians of the United Kingdom, 2019
Internal Medicine Residency, Singhealth, Singapore 2018
MBBS, Christian Medical College, Vellore, India 2005 -2011

Professional Appointments and Committee Memberships

Associate Consultant, Department of Neurology, National Neuroscience Institute (SGH Campus)
Fellow, Academy of Medicine, Singapore (Neurology)
Member, International Headache Society
Member, Royal College of Physicians, UK
Member, Singapore Medical Association

Awards

Research Interests

Publications and Research Trials

Spinal Cord Injury: Extent of disability, its complications and management – An overview for Primary care physicians (2023)

Publication: Journal of Physical Medicine Rehabilitation Studies & Reports

Nijanth M Raj, Nicodemus EO, Ei MZ, Chen J, Kappangathu VP

DOI: 10.47363/JPMRS/2023(5)165

Confidence in Neurology: How educators can help fight Neurophobia (2022)

Publication: South East Asian Journal of Medical Education

YJ Tan, KYL Juliana, Nijanth M Raj

DOI : 10.4038/seajme.v16i2.515

Isolated Infarctions of the Conus Medullaris: Clinical Features and Outcomes

Publication: Journal of Stroke & Cerebrovascular Diseases (2021)

You Jiang Tan, Nijanth M Raj

DOI: 10.1016/j.jstrokecerebrovasdis.2021.106055

A Practical Clinical Course Model for use during the COVID-19 Pandemic (2021)

Publication: South-East Asian Journal of Medical Education: Dec , 2021, 15 (2) : 23

You Jiang Tan, Nijanth M Raj

DOI: 10.4038/seajme.v15i2.270

Haemorrhagic Transformation following Ischaemic Stroke : A retrospective study (2020)

Publication: Nature -Scientific Reports

SD Pande, MM Win, Nijanth M Raj, EM Zaw,L Lolong, AS Tin

DOI: 10.1038/s41598-020-62230-5

Extradural Spinal Cavernous Hemangioma mimicking a dumb-bell shaped tumor, as a rare cause of myelopathy – Case report and review of literature (2020)

Publication: Interdisciplinary Neurosurgery

KV Prasanna, CS Ahmed, Nijanth M Raj, Poh WT, SK Dinesh

A Narrow Escape. High-energy Comminuted fractures of Sacrum and Pelvis – are they always associated with neurological deficits? (2019)

Publication: South East Asia Journal of Medical Sciences

Nijanth M Raj, Shakil A Chohan, KV Prasanna

DOI : https://doi.org/10.5281/zenodo.3723454

Sacral Insufficiency Fractures in patients with Spinal Cord Injury: Case report (2019)

Publication: Journal of Rehabilitation Medicine Clinical Communications

K V Prasanna, Nijanth M. Raj and Siddeshwar Patil

DOI: 10.2340/20030711-1000019

Baclofen in treatment of Stroke causing refractory hiccups (2016)

Publication: Archives of Case Reports in Clinical Medicine

Kwok KM, Cheong HY, Nijanth M Raj, Larik Ashfaq

DOI: 10.19104/crcm.2015.101

Effects of Fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD (2013)

Publication: JAMA – Journal of the American Medical Association

Thom S et al & Umpire Collaborative Group (Collaborator - Nijanth M)

Research Trials

MAESTOSO Trial – Efficacy of MLC1501 in Post Stroke subjects with motor deficits (2023) – Co Investigator
LIBREXIA Stroke Trial – Milvexian in participants after an acute stroke or TIA (2023) – Co Investigator
Burden and Care of Migraine in Singapore (2022)
UMPIRE Trial – Fixed dose combination strategy in patients with high risk CVD (2011- 2013) Trial Collaborator